Cc5013
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1252 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 158 | 316 | 118 | 14 | 54 | 584 |
| Plasma cell neoplasms | D054219 | — | — | 117 | 231 | 74 | 14 | 46 | 421 |
| Lymphoma | D008223 | — | C85.9 | 81 | 163 | 23 | 3 | 23 | 247 |
| B-cell lymphoma | D016393 | — | — | 34 | 64 | 8 | 1 | 10 | 96 |
| Follicular lymphoma | D008224 | — | C82 | 36 | 48 | 17 | 1 | 3 | 84 |
| Myelodysplastic syndromes | D009190 | — | D46 | 25 | 40 | 4 | 1 | 10 | 73 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 21 | 20 | 1 | 1 | 3 | 41 |
| T-cell lymphoma | D016399 | — | — | 12 | 20 | — | 1 | 3 | 30 |
| T-cell lymphoma peripheral | D016411 | — | — | 13 | 18 | — | 2 | 2 | 29 |
| Residual neoplasm | D018365 | — | — | 1 | 10 | 1 | 1 | 2 | 15 |
Show 11 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 40 | 84 | 12 | — | 13 | 124 |
| Leukemia | D007938 | — | C95 | 46 | 74 | 4 | — | 4 | 110 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 42 | 61 | 3 | — | 2 | 90 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 39 | 52 | 6 | — | 5 | 79 |
| Recurrence | D012008 | — | — | 27 | 31 | 8 | — | 2 | 59 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 29 | 36 | 4 | — | 4 | 59 |
| Lymphoid leukemia | D007945 | — | C91 | 22 | 39 | 3 | — | 3 | 57 |
| Preleukemia | D011289 | — | — | 19 | 30 | 3 | — | 7 | 54 |
| Syndrome | D013577 | — | — | 17 | 33 | 2 | — | 7 | 54 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 25 | 26 | 7 | — | 1 | 46 |
Show 23 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Waldenstrom macroglobulinemia | D008258 | — | C88.0 | 14 | 11 | — | — | — | 19 |
| Hodgkin disease | D006689 | — | C81 | 13 | 11 | — | — | — | 19 |
| Burkitt lymphoma | D002051 | — | C83.7 | 11 | 7 | — | — | 1 | 14 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 7 | 6 | — | — | — | 12 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 7 | 6 | — | — | 1 | 12 |
| Plasma cell leukemia | D007952 | — | C90.1 | 3 | 8 | — | — | 1 | 11 |
| Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 8 | 7 | — | — | — | 10 |
| Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 6 | 4 | — | — | — | 9 |
| Immunoblastic lymphadenopathy | D007119 | EFO_1001350 | C86.5 | 5 | 5 | — | — | 1 | 9 |
| Sezary syndrome | D012751 | — | C84.1 | 5 | 5 | — | — | — | 8 |
Show 131 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuroblastoma | D009447 | EFO_0000621 | — | 3 | — | — | — | — | 3 |
| Colonic neoplasms | D003110 | — | C18 | 2 | — | — | — | — | 2 |
| Rectal neoplasms | D012004 | — | — | 2 | — | — | — | — | 2 |
| Nervous system neoplasms | D009423 | — | — | 2 | — | — | — | — | 2 |
| Disease | D004194 | EFO_0000408 | R69 | 2 | — | — | — | — | 2 |
| Promyelocytic leukemia acute | D015473 | — | C92.4 | 2 | — | — | — | — | 2 |
| Mediastinal neoplasms | D008479 | — | C38.3 | 1 | — | — | — | — | 1 |
| Urethral neoplasms | D014523 | EFO_0003846 | — | 1 | — | — | — | — | 1 |
| Ureteral neoplasms | D014516 | EFO_0003844 | C66 | 1 | — | — | — | — | 1 |
| Salivary gland neoplasms | D012468 | EFO_0003826 | D11 | 1 | — | — | — | — | 1 |
Show 41 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Abnormal karyotype | D059786 | — | — | — | — | — | — | 1 | 1 |
| Hypoxia | D000860 | — | R09.02 | — | — | — | — | 1 | 1 |
| Patient compliance | D010349 | — | — | — | — | — | — | 1 | 1 |
| Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 1 | 1 |
| Patient satisfaction | D017060 | — | — | — | — | — | — | 1 | 1 |
| Personal satisfaction | D010549 | — | — | — | — | — | — | 1 | 1 |
| Patient preference | D057240 | — | — | — | — | — | — | 1 | 1 |
| Progression-free survival | D000077982 | — | — | — | — | — | — | 1 | 1 |
| Dermatomyositis | D003882 | EFO_0000398 | M33 | — | — | — | — | 1 | 1 |
| Oral ulcer | D019226 | — | — | — | — | — | — | 1 | 1 |
Show 6 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use